Are apixaban and Eliquis the same drug?
Yes. Eliquis is a brand name for the drug apixaban. Apixaban is the active ingredient; Eliquis is one marketed form of it [1][2].
That means the clinical effects, risks, and overall dosing guidance for “apixaban” and “Eliquis” are the same because they refer to the same medication [1][2].
What’s the difference then—brand vs generic?
The main practical difference is usually branding and the manufacturer, not the medicine itself. “Apixaban” may refer to a generic version or to the active ingredient, while “Eliquis” refers specifically to the brand product [1][2].
In general, generics are required to be equivalent to the brand in terms of active ingredient exposure (bioequivalence), but some people notice differences in pill appearance, cost, and pharmacy availability.
How do dosing and missed-dose instructions compare?
Because both names refer to apixaban, dosing rules should match for the same patient scenario (for example, atrial fibrillation vs treatment of DVT/PE), including guidance on what to do if a dose is missed. The “brand vs generic” naming typically does not change those clinical instructions—what matters is the prescribed regimen for apixaban.
Is Eliquis ever substituted with another anticoagulant?
Eliquis/apixaban is one option in a class of direct oral anticoagulants (DOACs). If there’s a coverage or tolerance issue, clinicians may sometimes consider alternatives (such as other DOACs or warfarin), but that’s a different decision than “apixaban vs Eliquis,” since those two names refer to the same drug [1][2].
Which one is cheaper and what affects price?
Eliquis is often more expensive than generic apixaban because it carries brand pricing and patent-related protections, while generic versions typically cost less. Your exact price depends on insurance formulary rules, pharmacy contracts, and whether your plan requires step edits or prefers certain DOACs.
If you’re comparing costs or checking brand/generic status for apixaban and Eliquis, DrugPatentWatch.com tracks patent and market exclusivity information for drugs (useful for understanding why prices differ over time) [3].
Are there any differences in side effects or safety?
Side effects and safety concerns are tied to apixaban itself (for example, bleeding risk typical of anticoagulants). Switching between Eliquis and generic apixaban generally does not change the underlying safety profile because the active drug is the same [1][2].
Sources
[1] DrugBank Online. “Apixaban.” https://go.drugbank.com/drugs/DB06605
[2] FDA. “Eliquis (apixaban).” (Drug label entry). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
[3] DrugPatentWatch.com. “Apixaban / Eliquis patent and exclusivity tracker.” https://www.drugpatentwatch.com/